Pandemic Panic Fueling Risky Drug Hoards

Spilled white pills from a prescription bottle on a wooden surface

Americans are being told to stockpile ivermectin and other prescription drugs, but the federal health record says that plan is built on shaky ground.

Quick Take

Ivermectin is an FDA-approved drug for some human parasite infections, but not for COVID-19.^[7]
The FDA says people should not use animal ivermectin products or take large doses.^[7]
Online sellers are packaging “emergency kits” around fear, shortages, and distrust of government.^[1]
Research on the pandemic shows that drug stockpiling grew with fear, misinformation, and supply worries.^[6]^[20]^[21]

What the Stockpile Pitch Is Selling

The headline promise is simple: buy a kit now and keep key medicines ready at home. One promoted package includes antibiotics, antifungal drugs, nausea medicine, and ivermectin capsules. That pitch taps into a real fear many Americans share after years of shortages, crowded pharmacies, and public distrust. It also turns a prescription drug into a prepper product, which is a major shift from normal medical use.

The appeal is easy to see. People do not like waiting for care, and many do not trust the system to work when needed. Surveys during the pandemic found that consumers were already stocking up on medicine and other essentials, while supply-chain research showed that prescription shortages were a real problem. But a fear-based buying spree is not the same thing as a safe medical plan, especially when the medicine is controversial.

What the Medical Evidence Says

The strongest official guidance cuts against the stockpiling message. The Food and Drug Administration (FDA) says ivermectin is approved for certain parasite infections and some skin uses, but it is not approved for preventing or treating COVID-19.^[7] The agency also warns that animal products are not the same as human medicine and says taking large doses can be dangerous. That matters because the promoted kits blur the line between legal access and safe use.

Doctors can sometimes prescribe approved medicines for unapproved uses when they judge that choice medically appropriate for an individual patient.^[7] That legal point is often used to justify off-label ivermectin use. But legality is not proof of benefit. The FDA says current clinical trial data do not show ivermectin works for COVID-19, and other medical groups have also recommended against using it outside clinical trials.^[2]^[11]^[13]^[14]

Why the Story Became Bigger Than One Drug

Ivermectin became a symbol in the larger pandemic fight over trust. A 2023 survey study found that use of ivermectin and hydroxychloroquine was linked with vaccine misinformation, lower trust in doctors and scientists, and stronger conspiracy beliefs.^[6] Another study found about 5.9 percent of adults with probable or definite COVID-19 reported using at least one non-evidence-based prescription treatment. That is a small share, but it is still a sign of how fast bad claims can spread.

The deeper issue is not just ivermectin. It is the wider habit of treating medicine like a survival commodity when people lose faith in public institutions. Research on the pandemic found that stockpiling behavior was common and often tied to stress, fear of shortages, and poor information.^[20]^[21] In that climate, sellers can frame a prescription kit as common sense. The risk is that readers confuse preparedness with proof and buy medicine before they have a real diagnosis or a real plan.